Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI South East AsiaCPhI South East Asia
Not Confirmed
Not Confirmed
16-18 July, 2025
Specialty & Agro Chemi...Specialty & Agro Chemical
Not Confirmed
Not Confirmed
29 June-01 July, 2025
Discovery EuropeDiscovery Europe
Not Confirmed
Not Confirmed
01-02 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI South East AsiaCPhI South East Asia
Industry Trade Show
Not Confirmed
16-18 July, 2025
Specialty & Agro Chemi...Specialty & Agro Chemical
Industry Trade Show
Not Confirmed
29 June-01 July, 2025
Discovery EuropeDiscovery Europe
Industry Trade Show
Not Confirmed
01-02 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/j-j-s-intra-cellular-buyout-bms-oncology-gambit-sanofi-s-blueprint-acquisition-drive-mega-deals-in-h1-2025
08 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nektar-therapeutics-reports-first-quarter-2025-financial-results-302450173.html
24 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nektar-announces-clinical-trial-agreement-to-evaluate-rezpegaldesleukin-in-patients-with-new-onset-type-1-diabetes-mellitus-302383052.html
10 Feb 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nektar-therapeutics-receives-fast-track-designation-for-rezpegaldesleukin-for-the-treatment-of-moderate-to-severe-atopic-dermatitis-302371995.html
02 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ampersand-capital-partners-completes-acquisition-of-nektar-therapeutics-peg-reagent-manufacturing-business-launching-newly-branded-gannet-biochem-302319679.html
18 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nektar-therapeutics-presents-first-preclinical-data-from-novel-csf-1-program-nktr-422-at-2024-american-college-of-rheumatology-acr-convergence-302307672.html
07 Nov 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/nektar-and-collaborators-present-late-breaking-results-from-phase-2-study-of-nktr-255-for-the-treatment-of-radiation-induced-lymphopenia-in-locally-advanced-non-small-cell-lung-cancer-patients-at-society-for-immunotherapy-of-cance-302298158.html
Excipients
Inspections and registrations
ABOUT THIS PAGE
Nektar Therapeutics is a supplier offers 6 products (APIs, Excipients or Intermediates).
Find a price of NKTR-255 DRUG PRODUCT bulk with DMF offered by Nektar Therapeutics
Find a price of NKTR-255 DRUG SUBSTANCE bulk with DMF offered by Nektar Therapeutics
Find a price of Amikacin bulk offered by Nektar Therapeutics
Find a price of Lysine bulk offered by Nektar Therapeutics
Find a price of Macrogol bulk offered by Nektar Therapeutics
Find a price of PEG2MAL40K bulk offered by Nektar Therapeutics